Mechanisms of couplon-linked skeletal muscle myopathies
Mechanisms of couplon-linked skeletal muscle myopathies
批准号:
10437729
负责人:
SUSAN L HAMILTON
金额:
$66.51万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-01 至 2024-06-30
关键词:
AgeCalmodulinCalsequestrinChemicalsCodeCouplingDantroleneDiseaseDropsElectrophysiology (science)FDA approvedHomeostasisHumanImageImmunoprecipitationImpairmentInterventionKineticsLeadLinkMacromolecular ComplexesMalignant hyperpyrexia due to anesthesiaMass Spectrum AnalysisMechanicsMediatingMembraneMethodsModelingMolecular ChaperonesMolecular ConformationMonitorMusMuscleMuscle functionMutationMyopathyNifedipinePathologicPathway interactionsPharmaceutical PreparationsPhosphorylationPhosphotransferasesPolymersProteinsReactionRoleRyanodineRyanodine Receptor Calcium Release ChannelRyanodine ReceptorsSarcoplasmic ReticulumSeveritiesSignal PathwaySiteSkeletal MuscleSymptomsTestingconformational conversiondefined contributiondepolymerizationdesigndisease-causing mutationeffective interventionendoplasmic reticulum stressfallsimmunocytochemistryimprovedmouse modelpolymerizationresponserestorationvoltage
中文摘要
骨骼肌横管中的L钙通道(CaV1.1)、兰尼定受体(RyR_1)
肌浆网(SR)和钙调蛋白(Casq1)在交界性SR(JSR)腔内是肌浆网(JSR)的关键成分。
一种被称为偶联的大分子复合体,它调节兴奋-收缩耦合(ECC)。基因突变
RyR1、CaV1.1和Casq1是人类肌病的基础,具有重叠的病理特征。除了
丹曲林用于恶性高热,目前还没有FDA批准的针对这些肌病的干预措施。老鼠
随着CaV1.1(E1014K)、RyR1(I4895T)和Casq1(D244G)的突变,肌肉疾病的严重性会增加
随着年龄的增长,其肌肉表现为Casq1错误定位和持续的内质网应激。此应用程序旨在
阐明CaMKII依赖途径中突变相关改变导致ER的机制
应激/UPR和肌肉疾病。我们将检验这一普遍假设,即偶联性肌病的相似性
不同偶联蛋白的突变是由高度合作的双向功能偶联引起的
在CaV1.1、CaMKII、RyR1和Casq1之间。我们的目标是:1.定义改变的CaV1.1功能状态的作用
偶联肌病中的转化和CaMKII激活。2.量化与对联疾病相关的影响
RyR1磷酸化突变及其对CaV1.1功能和Casq1的影响
保留在JSR。3.明确Casq1错位和内质网应激在复联肌病中的作用。我们会
也测试4PBA的能力,它可以缓解内质网应激,改善由以下原因引起的肌肉疾病的肌肉功能
偶联蛋白的突变。
英文摘要
The skeletal muscle L-type Ca2+ channel (CaV1.1) in the transverse tubules, the ryanodine receptor (RyR1) in the
sarcoplasmic reticulum (SR), and calsequestrin (Casq1) in the lumen of junctional SR (jSR) are key components of
a macromolecular complex termed the couplon which regulates excitation-contraction coupling (ECC). Mutations in
RyR1, CaV1.1, and Casq1 underlie human myopathies with overlapping pathological features. With the exception of
dantrolene for malignant hyperthermia, there are no FDA approved interventions for any of these myopathies. Mice
with a mutations CaV1.1 (E1014K), RyR1 (I4895T) and Casq1 (D244G) develop myopathies that increase in severity
with age and their muscles display Casq1 mislocalization and persistent ER stress. This application is designed to
elucidate the mechanisms by which mutation-associated alterations in a CaMKII-dependent pathway lead to ER
stress/UPR and muscle disease. We will test the general hypothesis that the similarities in couplon myopathies
arising from mutations in different couplon proteins are due to highly cooperative, bidirectional functional coupling
between CaV1.1, CaMKII, RyR1 and Casq1. Our aims are to: 1. Define the roles of altered CaV1.1 functional state
transitions and CaMKII activation in couplon myopathies. 2. Quantify the effects of couplon disease-associated
mutations on RyR1 phosphorylation and the phosphorylation-mediated effects on CaV1.1 function and Casq1
retention at the jSR. 3. Define the roles of Casq1 mislocalization and ER stress in the couplon myopathies. We will
also test the ability of 4PBA, which alleviates ER stress, to improve muscle function in myopathies that arise from
mutations in couplon proteins.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1085/jgp.202213143
发表时间:
2022-09-05
期刊:
The Journal of general physiology
影响因子:
--
作者:
[]
通讯作者:
Lifetime of autofluorescence: A novel method to determine murine skeletal muscle fiber types.
自发荧光的寿命:一种确定小鼠骨骼肌纤维类型的新方法。
DOI:
--
发表时间:
2022
期刊:
The Journal of general physiology
影响因子:
--
作者:
[Manno,C, Tammineni,E, Oropeza,Y, Figueroa,L, Rios,E]
通讯作者:
Rios,E
Mechanisms of couplon-linked skeletal muscle myopathies
-
批准号:10198771
-
项目类别:
-
资助金额:$65.16万
-
财政年份:2018
-
负责人:SUSAN L HAMILTON
-
依托单位:
Mechanisms of couplon-linked skeletal muscle myopathies
-
批准号:9751769
-
项目类别:
-
资助金额:$67.18万
-
财政年份:2018
-
负责人:SUSAN L HAMILTON
-
依托单位:
RYANODINE RECEPTOR FROM RABBIT SKELETAL MUSCLE
-
批准号:8361061
-
项目类别:
-
资助金额:$1.23万
-
财政年份:2011
-
负责人:SUSAN L HAMILTON
-
依托单位:
RYANODINE RECEPTOR FROM RABBIT SKELETAL MUSCLE
-
批准号:8168531
-
项目类别:
-
资助金额:$1.08万
-
财政年份:2010
-
负责人:SUSAN L HAMILTON
-
依托单位:
RYANODINE RECEPTOR FROM RABBIT SKELETAL MUSCLE
-
批准号:7953759
-
项目类别:
-
资助金额:$3.48万
-
财政年份:2008
-
负责人:SUSAN L HAMILTON
-
依托单位:
Sub-Project #3
-
批准号:7436118
-
项目类别:
-
资助金额:$22.64万
-
财政年份:2007
-
负责人:SUSAN L HAMILTON
-
依托单位:
Basis of Muscle Dysfunction in Malignant Hyperthermia and Central Core Disease
-
批准号:7271647
-
项目类别:
-
资助金额:$8.31万
-
财政年份:2006
-
负责人:SUSAN L HAMILTON
-
依托单位:
Sub-Project #3
-
批准号:7075004
-
项目类别:
-
资助金额:$23.75万
-
财政年份:2006
-
负责人:SUSAN L HAMILTON
-
依托单位:
Basis of Muscle Dysfunction in Malignant Hyperthermia and Central Core Disease
-
批准号:7215722
-
项目类别:
-
资助金额:$36.72万
-
财政年份:2006
-
负责人:SUSAN L HAMILTON
-
依托单位:
Basis of Muscle Dysfunction in Malignant Hyperthermia and Central Core Disease
-
批准号:7105819
-
项目类别:
-
资助金额:$24.66万
-
财政年份:2006
-
负责人:SUSAN L HAMILTON
-
依托单位:
Basis of Muscle Dysfunction in Malignant Hyperthermia and Central Core Disease
-
批准号:7668279
-
项目类别:
-
资助金额:$5.85万
-
财政年份:2006
-
负责人:SUSAN L HAMILTON
-
依托单位:
Basis of Muscle Dysfunction in Malignant Hyperthermia and Central Core Disease
-
批准号:7570663
-
项目类别:
-
资助金额:$22.42万
-
财政年份:2006
-
负责人:SUSAN L HAMILTON
-
依托单位:
Basis of Muscle Dysfunction in Malignant Hyperthermia and Central Core Disease
-
批准号:7380011
-
项目类别:
-
资助金额:$22.42万
-
财政年份:2006
-
负责人:SUSAN L HAMILTON
-
依托单位:
RYANODINE RECEPTOR FROM RABBIT SKELETAL MUSCLE
-
批准号:7598588
-
项目类别:
-
资助金额:$4.07万
-
财政年份:2006
-
负责人:SUSAN L HAMILTON
-
依托单位:
Basis of Muscle Dysfunction in Malignant Hyperthermia and Central Core Disease
-
批准号:7759146
-
项目类别:
-
资助金额:$22.2万
-
财政年份:2006
-
负责人:SUSAN L HAMILTON
-
依托单位:
RYANODINE RECEPTOR FROM RABBIT SKELETAL MUSCLE
-
批准号:7357780
-
项目类别:
-
资助金额:$3.76万
-
财政年份:2005
-
负责人:SUSAN L HAMILTON
-
依托单位:
2006 Muscle: Excitation/Contraction Coupling Gordan Conference
-
批准号:7058930
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2005
-
负责人:SUSAN L HAMILTON
-
依托单位:
Nitrosylation and Oxidation of RYR1 in Muscle Function
-
批准号:6708189
-
项目类别:
-
资助金额:$40.74万
-
财政年份:2004
-
负责人:SUSAN L HAMILTON
-
依托单位:
RYANODINE RECEPTOR FROM RABBIT SKELETAL MUSCLE
-
批准号:7181084
-
项目类别:
-
资助金额:$1.85万
-
财政年份:2004
-
负责人:SUSAN L HAMILTON
-
依托单位:
Nitrosylation and Oxidation of RYR1 in Muscle Function
-
批准号:7372002
-
项目类别:
-
资助金额:$40.22万
-
财政年份:2004
-
负责人:SUSAN L HAMILTON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
好忘方通过STIM1-Ca2+/Calmodulin-eEF2信号通路治疗阿尔茨海默病的机制研究
-
批准号:82104416
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:刘妍
-
依托单位:
凡纳滨对虾Ca2+/Calmodulin信号通路在低盐逆境条件下的应答调节作用研究
-
批准号:31602135
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2016
-
负责人:黄文
-
依托单位:
VEGF下调Calmodulin维持肝窦内皮细胞窗孔结构在肝纤维化中的作用及机制
-
批准号:81600485
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2016
-
负责人:程恒辉
-
依托单位:
Calmodulin的N环和C环与心肌CaV1.2钙通道的多个结合位点交互作用介导其Ca2+依赖性失活的机制研究
-
批准号:31471091
-
项目类别:面上项目
-
资助金额:86.0万元
-
批准年份:2014
-
负责人:郝丽英
-
依托单位:
Ca2+/Calmodulin通路与炎性肌损伤免疫反应的相关性研究
-
批准号:81371924
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:廖华
-
依托单位:
虎杖苷通过靶向抑制Ca2+/calmodulin激活的calcineurin-NFAT信号通路治疗心肌肥大的研究
-
批准号:81200122
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:邓建新
-
依托单位:
Ca2+/Calmodulin/NFATc1信号通路在双膦酸盐诱发破骨细胞生成抑制中作用及机制研究
-
批准号:81270965
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2012
-
负责人:戚孟春
-
依托单位:
出血性血小板病ADAM17和Calmodulin介导的血小板GPⅠb-Ⅸ-Ⅴ亚基水解活性研究及益气活血方的干预效应
-
批准号:81072945
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2010
-
负责人:沈霖
-
依托单位:
L型钙通道调节机制中calpastatin 和calmodulin的相互作用
-
批准号:30670761
-
项目类别:面上项目
-
资助金额:26.0万元
-
批准年份:2006
-
负责人:郝丽英
-
依托单位: